Clade Ib Mpox Virus: How Can We Respond?

Lin Ai1, Xinyi Cui2, Yanqiu Zhou1

  • 1Institute of Microbiology Laboratory, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.

China CDC Weekly
|August 20, 2025
PubMed

Insights

Mpox virus Clade Ib, first identified in 2023, is a growing global health concern due to its rapid spread and severe outcomes. This review covers its characteristics, spread, and control strategies.

Area of Science:

  • * Virology and Epidemiology
  • * Public Health and Infectious Diseases

Background:

  • * Mpox virus Clade Ib emerged in the Democratic Republic of the Congo in September 2023.
  • * Rapid international spread to 12 non-African countries documented by July 2024.
  • * Clade Ib presents increased transmissibility and risk of severe illness, particularly in vulnerable populations.

Purpose of the Study:

  • * To provide a comprehensive overview of mpox virus Clade Ib.
  • * To detail its genetic features, epidemiological trends, and transmission dynamics.
  • * To discuss current and needed prevention and control strategies.

Main Methods:

  • * Review of current scientific literature and epidemiological data.
  • * Analysis of genetic characteristics and transmission patterns.
  • * Synthesis of public health interventions and control measures.

Main Results:

  • * Clade Ib demonstrates heightened transmissibility compared to previous strains.
  • * Higher rates of severe mpox symptoms and mortality observed, especially in children, pregnant individuals, and immunocompromised groups.
  • * Primary transmission routes include sexual contact, close household contact, and healthcare exposure.

Conclusions:

  • * Mpox virus Clade Ib represents a significant and evolving global health threat.
  • * Targeted public health strategies are crucial for effective prevention and control.
  • * Ongoing surveillance and research are essential to manage this emerging infectious disease.